The case upgrades events since the Court's ruling against Myriad Genetics on March 29, 2010 and ought to be used in conjunction with Gene Patents (A). Against Multitude, the earlier ruling was revoked by a US Appeals Court on July 29, 2011. On September 16, 2011, the first major overhaul of US Patent law in nearly 60 years was signed into law.
Among other provisions, the US transferred to a first-- to-file priority as was the practice in most of the remaining part of the world, when granting patents. Many felt this change would help reduce the amount of patent litigation. Within five days of that decision, the Supreme Court remanded the Myriad case back to the Court of Appeals for reconsideration.
PUBLICATION DATE: March 30, 2012 PRODUCT #: 812130-HCB-ENG
This is just an excerpt. This case is about INNOVATION & ENTREPRENEURSHIP
Related Case Solutions & Analyses:
Microsoft: Multimedia Publications (A)
Marcia Radosevich and Health Payment Review–1989 (A)
Health Stop Retail Medical Centers (A): Strategy
Cash Budgeting Cash Mangement
Mayers Tap Inc. (C)
Shaping the Future of Solar Power: Climate Change, Industrial Policy and Free Trade
Water Policy Priorities Along the U.S.-Mexico Border
Paragon Legal, A New Model (A)
Willow Creek Community Church, What Really Makes a Difference
StudyBlue (A)
